Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Completed

Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer

NCT03238196

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • Baptist Memorial Hospital MEMPHIS Memphis, Tennessee, United States
View Trial Details
Completed

CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO

NCT03227328

Conditions
Breast Diseases, Breast Neoplasms, Hormone Receptor Negative Breast Cancer, +6 more
Locations
  • U.O. Oncologia Medica, P.O. Bellaria-Maggiore Bologna, BO, Italy
  • UO Oncologia Medica IRST IRCCS Meldola, FC, Italy
  • Dip. Medicina Interna e Riabilitazione - U.O. Medicina Interna Oncologica, Ospedale Ramazzini Carpi, MO, Italy
  • Dip. Oncologia-Ematologia - U.O. Oncologia Medica,Azienda USL di Piacenza - Ospedale Civile Piacenza, PC, Italy
View all 20 locations
View Trial Details
Completed

Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer

NCT02980341

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Southeastern Regional Medical Center Newnan, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Completed

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer

NCT03901339

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • HonorHealth Research Institute Avondale, Arizona, United States
  • Arizona Oncology Associates, PC Tucson, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of California, San Diego Moores Cancer Center La Jolla, California, United States
View all 113 locations
View Trial Details
Completed

Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer

NCT03409198

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Institut Jules Bordet Brussels, Brussels Capital, Belgium
  • Cliniques universitaires Saint-Luc Brussels, Brussels Capital, Belgium
  • CHU UCL Namur Namur, Belgium
  • Soerlandet Hospital HF Kristiansand Kristiansand, Norway
View Trial Details
Completed

Telephone Support for Metastatic Breast Cancer Patients

NCT03998618

Conditions
Breast Diseases, Breast Neoplasms, Fatigue, +7 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States
  • Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Community Health Network Indianapolis, Indiana, United States
View Trial Details

Related conditions